CG vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

CG

59.3
AI Score
VS
CG Wins

CNS

55.5
AI Score

Investment Advisor Scores

CG

59score
Recommendation
HOLD

CNS

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CG CNS Winner
Revenue 254.00M 94.41M CG
Net Income -132.20M 29.96M CNS
Net Margin -52.0% 31.7% CNS
ROE -1.8% 9.9% CNS
ROA -0.4% 6.7% CNS
Total Assets 29.84B 450.12M CG
Cash 1.67B 193.73M CG
Free Cash Flow -1.27B 4.31M CNS

Relative Price Performance (Last 90 Days)

CG 1M: +8.7% · 3M: -8.1% CNS 1M: +6.3% · 3M: +17.0%

Current Technical Phase

CG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.4 · Price: $46.02

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 60

RSI (14): 60.3 · Price: $82.27

Fundamentals Snapshot

Metric CG CNS
Market Cap
Forward P/E 9.0 21.2
Trailing P/E 31.1 25.1
Revenue (TTM)
Revenue Growth -0.9% 0.1%
Gross Margin 0.9% 0.5%
Operating Margin -2.3% 0.3%
EPS 1.46 3.25
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CG is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.